60 Degrees Pharmaceuticals Study Results Published by New Microbes and New Infections Demonstrate Tafenoquine Exhibits Broad Spectrum Antifungal Activity
August 30, 2023 07:32 ET | Sixty Degrees Pharmaceuticals
Data showed tafenoquine does not exhibit cross-susceptibility with fluconazole against Candida spp.Effective treatment of drug-resistant Candida infections is an unmet need in U.S. marketPresumed mode...
Candida + auris
Hardy Diagnostics Releases HardyCHROM™ Candida + auris
October 20, 2021 06:00 ET | Hardy Diagnostics
SANTA MARIA, Calif., Oct. 20, 2021 (GLOBE NEWSWIRE) -- Hardy Diagnostics is pleased to announce its release of HardyCHROM™ Candida + auris, a chromogenic media recommended for the selective...
Stellar Biotechnologies to Present at ICAAC 2012 Conference on September 9 - 12, 2012
June 20, 2012 09:05 ET | Stellar Biotechnologies, Inc.
PORT HUENEME, CA--(Marketwire - Jun 20, 2012) - Stellar Biotechnologies, Inc. ("Stellar") (TSX VENTURE: KLH) (PINKSHEETS: SBOTF) (FRANKFURT: RBT) is pleased to announce that Stellar scientists will...